Brickell Biotech, Inc. Banner Image

Brickell Biotech, Inc.

  • Ticker BBI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Brickell Biotech, Inc. Logo Image
  • 11-50 Employees
  • Based in Boulder, Colorado
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases. Brickell’s pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions. Brickell’s executive management team and board of directors bring extensiveMore experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. Brickell’s strategy is to leverage this experience to in-license, acquire, develop, and commercialize innovative products that Brickell believes can be successful in the currently underserved dermatology global marketplace.
Brickell Biotech, Inc.

Most Recent Annual Report

Brickell Biotech, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports